361 Capital’s Medpace MEDP Stock Holding History

361 Capital’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-16,002	Closed	-$1.34M	–	346
2019 Q4	$1.34M	Sell	16,002 -17,687	-53%	-$1.37M	0.37%	110
2019 Q3	$2.83M	Buy	+33,689	New	+$2.55M	0.52%	37
2019 Q1	–	Sell	-46,837	Closed	-$2.48M	–	372
2018 Q4	$2.48M	Buy	46,837 +19,484	+71%	+$1.07M	0.51%	42
2018 Q3	$1.64M	Sell	27,353 -15,820	-37%	-$865K	0.36%	144
2018 Q2	$1.86M	Buy	43,173 +1,403	+3%	+$56.7K	0.42%	55
2018 Q1	$1.46M	Buy	+41,770	New	+$1.53M	0.36%	143

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

361 Capital's MEDP Position: Q1 2020 in Review

361 Capital sold out of Medpace (MEDP) in Q1 2020, closing a stake of 16,002 shares — an estimated $1.34M sold.

361 Capital first reported a position in MEDP in Q1 2018 and held it in 6 quarters. The position peaked at $2.83M in Q3 2019. 269 funds tracked by Wall St. Rank hold MEDP as of Q1 2020.

361 Capital reported no remaining Medpace position as of Q1 2020 after selling out during the quarter.
361 Capital sold 16,002 Medpace shares in Q1 2020, an estimated $1.34M.
361 Capital first reported a position in Medpace in Q1 2018 and held it in 6 quarters.
361 Capital's Medpace position peaked at $2.83M in Q3 2019.
269 funds tracked by Wall St. Rank held Medpace as of Q1 2020.

Based on 361 Capital's 13F filing for Q1 2020, filed 13 May 2020.